Abilify Asimtufii 960 mg/3.2mL
Aripiprazole · INJECTION, SUSPENSION, EXTENDED RELEASE · Otsuka America Pharmaceutical, Inc
No Recall History
Plain English
Abilify Asimtufii is a injection, suspension, extended release containing aripiprazole at 960 mg/3.2mL, taken intramuscular. Manufactured by Otsuka America Pharmaceutical, Inc.
Key Facts
- Brand Name
- Abilify Asimtufii
- Generic Name
- Aripiprazole
- NDC Code (Product)
59148-114- Manufacturer
- Otsuka America Pharmaceutical, Inc
- Strength
- 960 mg/3.2mL
- Dosage Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- NDA217006
- Drug Class
- Atypical Antipsychotic [EPC]
- Marketing Start
- 04/27/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Abilify Asimtufii used for?
Abilify Asimtufii contains Aripiprazole. It is a injection, suspension, extended release taken intramuscular. Consult your doctor for specific uses.
Is Abilify Asimtufii a controlled substance?
Abilify Asimtufii is not classified as a controlled substance by the DEA.
What is the generic name for Abilify Asimtufii?
The generic name for Abilify Asimtufii is Aripiprazole. There are 12 other brand versions of Aripiprazole.
What is the NDC code for Abilify Asimtufii 960 mg/3.2mL?
The NDC (National Drug Code) for Abilify Asimtufii 960 mg/3.2mL is 59148-114, listed by Otsuka America Pharmaceutical, Inc.